Latest Breaking News On - Mary tagliaferri - Page 1 : comparemela.com

Nektar Therapeutics (NASDAQ:NKTR) Q1 2024 Earnings Call Transcript

Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments

FARMINGDALE, NY, Feb. 01, 2024 Enzo Biochem, Inc. , a leading life science company, announced the voting results from its Annual Meeting held on January 31, 2024 and officer appointments. .

Nektar Therapeutics (NASDAQ:NKTR) Q3 2023 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Nektar Therapeutics Third Quarter 2023 Financial Results Conference Call.

Nektar Therapeutics Announces Two Abstracts Accepted at EADV Congress 2023 for Rezpegaldesleukin, a First-in-Class Selective Regulatory T-cell Therapy

– Phase 1b Safety and Efficacy Data for Rezpegaldesleukin in Moderate to Severe Atopic Dermatitis to be Presented in Late-Breaking Oral Presentation – SAN FRANCISCO, Oct. 2, 2023 /PRNewswire/ .

Nektar Therapeutics (NKTR) Announces New Clinical Study Collaboration with Cellular Biomedicine Group to Evaluate NKTR-255